Thus, one mechanism for APOE4 exacerbation of amyloid pathology in AD is caused by the decreased sialylation of APOE4 leading to issues with lipidation and ultimately preference for VLDL, reduced binding affinity inducing issues with amyloid beta clearance [57, 58]. Here, APOE is linked to Alzheimer disease.